Review Article
Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature
Table 1
LncRNAs involved in vascular remodeling.
| Type | Cellular origin | LncRNAs | Regulation | Target genes | Related functions | References |
| Hypertension | VSMC | TUG1 | | miR-145-5p | promote migration and proliferation of VSMCs | Shi et al.[28] | VSMC | AK098656 | | myosin heavy chain-11/ fibronectin-1 | promote VSMC phenotypic switch | Jin et al. [29] | VSMC | TRPV1 | | PI3K/Akt | inhibit VSMC phenotypic modulation | Zhang et al. [30] | VSMC/EC | GAS5 | | β-catenin | affect endothelial activation proliferation, andVSMC phenotypic conversion | Wang et al. [31] | VSMC | Giver | | Nr4a3 | promote oxidative stress, VSMC proliferation and vascular inflammation | Das et al. [32] | VSMC | Lnc-Ang362 | | miR221/222 | promote VSMC proliferation | Leung et al. [33] |
| Atherosclerosis | VSMC | H19 | | ACP5 Wnt/β-catenin | promote VSMC proliferation and inhibit apoptosis | Huang et al. [9] Zhang et al. [11] | VSMC/EC/ Macrophage | TUG1 | | miR-21/PTEN miR-133a miR26a/FGF1 | promote VSMC proliferation, facilitate EC/ macrophage apoptosis | Li et al. [37] Chen et al. [38] Zhang et al. [39] | VSMC | UCA1 | | miR-26a/PTEN | suppress VSMC proliferation | Tian et al. [40] | VSMC | MEG3 | | miR-26a/Smad1 | suppress VSMC proliferation | Bai et al. [41] | VSMC | APPAT | | miR-647, miR-135b | affect VSMC phenotype shift | Meng et al. [14] | VSMC | lincRNA-p21 | | P53 | regulate neointima formation, VSMC proliferation and apoptosis | Wu et al. [42] | VSMC | Neat1 | | SM-contractile gene | modulate VSMC phenotype conversion | Ahmed et al. [43] |
| Arterial aneurysm | VSMC | HIF1A-AS1 | | caspase-3 | regulate VSMC apoptosis | He et al. [47] | VSMC | lincRNA-p21 | | TGF-β1 signaling | hinder proliferation and promote apoptosis of VSMCs | Hu et al. [48] |
|
|
VSMC: vascular smooth muscle cell; EC: endothelial cell; TUG1: taurine upregulated 1; TRPV1: transient receptor potential vanilloid type 1; GAS5: growth block specificity 5; Giver: growth factor-and proinflammatory cytokine–induced vascular cell-expressed lncRNA; UCA1: urothelial carcinoma-associated; MEG3: maternally expressed gene 3; APPAT: atherosclerotic plaque pathogenesis associated transcript; lincRNA-p21: long intergenic noncoding RNA-p21; Neat1: nuclear paraspeckle assembly transcript 1; HIF1A-AS1: HIF1 alpha-antisense RNA1; ACP5: acid phosphatase 5; SM: smooth muscle.
|